TGFB1 and neoplasm: Researchers have developed BsAb (BiTP) targeting TGF-β and PD-L1 by using the Check-BODY platform and found that BiTP remarkably increases NK cell proliferation and cytotoxicity in the 4T1 mouse tumor model group 183.